GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2 | affects expression | EXP | | 6480464 | CTD | epigallocatechin gallate affects the expression of BCL2 protein | PMID:22000973 | Bcl2 | multiple interactions | EXP | | 6480464 | CTD | [epigallocatechin gallate co-treated with coenzyme Q10] inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; epigallocatechin gallate inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein] | PMID:28056603 PMID:33393703 | Bcl2 | affects expression | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | epigallocatechin gallate affects the expression of BCL2 protein | PMID:15975156 | Bcl2 | decreases expression | ISO | Bcl2 (Mus musculus) | 6480464 | CTD | epigallocatechin gallate results in decreased expression of BCL2 protein | PMID:34600025 | Bcl2 | decreases expression | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | epigallocatechin gallate analog results in decreased expression of BCL2 protein; epigallocatechin gallate results in decreased expression of BCL2 protein | PMID:15657356 PMID:16115949 PMID:20149610 | Bcl2 | multiple interactions | ISO | Bcl2 (Mus musculus) | 6480464 | CTD | epigallocatechin gallate affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of BCL2 protein]; epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA]; epigallocatechin gallate inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] | PMID:18656336 PMID:36056792 PMID:37286014 | Bcl2 | multiple interactions | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | [arsenic trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2 protein; [decitabine co-treated with epigallocatechin gallate] affects the expression of BCL2 mRNA; CAT protein inhibits the reaction [epigallocatechin gallate analog results in decreased expression of BCL2 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] | PMID:12672908 PMID:16115949 PMID:18250043 PMID:19557821 PMID:20950636 | |
Go Back to source page | Continue to Ontology report |